CD4 and neoplasm: Moreover, the downmodulation of CD4+CD25+ Treg cells, induced by L-M therapy 11, may favor the therapeutic effect of gemcitabine and contribute to the overall cellular and molecular events leading to tumor eradication and stable antitumor immune response observed in these models.